SHUKRA PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of SHUKRA PHARMACEUTICALS have increased by 187.19% YoY .
The Earnings Per Share (EPS) of SHUKRA PHARMACEUTICALS has increased by 50.44 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SHUKRA PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524632]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹59 Cr | ₹20 Cr | ₹11 Cr | ₹1,184,602 Cr | ₹5.66 Cr |
| Expenses | ₹53 Cr | ₹18 Cr | ₹9.75 Cr | ₹1,030,567 Cr | ₹4.01 Cr |
| Operating Profit (Excl OI) | ₹5.36 Cr | ₹2.89 Cr | ₹1.44 Cr | ₹154,035 Cr | ₹1.65 Cr |
| Other Income | ₹1.20 Cr | ₹0.08 Cr | ₹0.36 Cr | ₹970 Cr | ₹0.04 Cr |
| Interest | ₹0.28 Cr | ₹0.29 Cr | ₹0.03 Cr | ₹206 Cr | ₹0.00 Cr |
| Depreciation | ₹1.84 Cr | ₹1.66 Cr | ₹1.47 Cr | ₹147,819 Cr | ₹0.96 Cr |
| Profit Before Tax | ₹4.44 Cr | ₹1.02 Cr | ₹0.10 Cr | ₹17,084 Cr | ₹0.72 Cr |
| Profit After Tax | ₹4.41 Cr | ₹0.75 Cr | ₹0.19 Cr | ₹3,560 Cr | ₹0.46 Cr |
| Earnings Per Share (Rs) | ₹16.94 | ₹11.26 | ₹4.79 | ₹1.20 | ₹0.23 |
| PAT Margin (%) | 24.86 | 7.49 | 3.66 | 1.68 | 0.26 |
| ROE(%) | 44.70 | 21.16 | 4.70 | 1.21 | 0.23 |
| ROCE(%) | 44.24 | 18.85 | 5.79 | 0.54 | 0.77 |
| Total Debt/Equity(x) | 0.05 | 0.20 | 0.21 | 0.63 | 0.52 |
Key Financials |
||
| Market Cap | : | ₹ 445.8 Cr |
| Revenue (TTM) | : | ₹ 38.5 Cr |
| Net Profit(TTM) | : | ₹ 14.4 Cr |
| EPS (TTM) | : | ₹ 3.3 |
| P/E (TTM) | : | 30.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SHUKRA PHARMACEUTICALS | 27.3% | 74.6% | 222.3% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.7% | 45.7% |
| CIPLA | 1.7% | 0.5% | 23.7% |
| DR REDDYS LABORATORIES | 5.7% | 12.4% | 18.5% |
| ZYDUS LIFESCIENCES | -1.4% | 3.1% | 44.8% |
| DIVIS LABORATORIES | -0.1% | -2.2% | 56.9% |
| MANKIND PHARMA | 4.2% | 9.8% | 49.8% |
| TORRENT PHARMACEUTICALS | 2.2% | 10.6% | 61.7% |
| LUPIN | 4.1% | 5.1% | 71.7% |
SHUKRA PHARMACEUTICALS Revenues
[BOM: 524632]
| Y-o-Y | 187.19 % |
| 5 Yr CAGR | 79.56 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹59 Cr | 187.19 | |
| Mar2023 | ₹20 Cr | 82.98 | |
| Mar2022 | ₹11 Cr | -100.00 | |
| Mar2021 | ₹1,184,602 Cr | 20,929,263.25 | |
| Mar2020 | ₹5.66 Cr | - | |
SHUKRA PHARMACEUTICALS Operating Profit
[BOM: 524632]
| Y-o-Y | 85.83 % |
| 5 Yr CAGR | 34.29 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹5.36 Cr | 85.83 | |
| Mar2023 | ₹2.89 Cr | 99.86 | |
| Mar2022 | ₹1.44 Cr | -100.00 | |
| Mar2021 | ₹154,035 Cr | 9,341,035.23 | |
| Mar2020 | ₹1.65 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -35.27 % |
| 5 Yr CAGR | -25.20 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 9.12% | -35.27 | |
| Mar2023 | 14.09% | 9.22 | |
| Mar2022 | 12.9% | -0.77 | |
| Mar2021 | 13% | -55.37 | |
| Mar2020 | 29.13% | - | |
SHUKRA PHARMACEUTICALS Profit After Tax
[BOM: 524632]
| Y-o-Y | 486.82 % |
| 5 Yr CAGR | 75.74 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹4.41 Cr | 486.82 | |
| Mar2023 | ₹0.75 Cr | 299.47 | |
| Mar2022 | ₹0.19 Cr | -99.99 | |
| Mar2021 | ₹3,560 Cr | 770,549.35 | |
| Mar2020 | ₹0.46 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 231.91 % |
| 5 Yr CAGR | 212.70 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 24.86 % | 231.91 | |
| Mar2023 | 7.49 % | 104.64 | |
| Mar2022 | 3.66 % | 117.86 | |
| Mar2021 | 1.68 % | 546.15 | |
| Mar2020 | 0.26 % | - | |
SHUKRA PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524632]
| Y-o-Y | 50.44 % |
| 5 Yr CAGR | 192.95 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹17 | 50.44 | |
| Mar2023 | ₹11 | 135.07 | |
| Mar2022 | ₹4.79 | 299.17 | |
| Mar2021 | ₹1.20 | 421.74 | |
| Mar2020 | ₹0.23 | - | |
SHUKRA PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524632]
| Y-o-Y | 134.69 % |
| 5 Yr CAGR | 175.32 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 44.24% | 134.69 | |
| Mar2023 | 18.85% | 225.56 | |
| Mar2022 | 5.79% | 972.22 | |
| Mar2021 | 0.54% | -29.87 | |
| Mar2020 | 0.77% | - | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹101.8 |
| Current MarketCap | : | ₹ 445.8 Cr |
| Updated EOD on | : | Dec 20,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 27.3% |
74.6% |
222.3% |
| SENSEX | -5% |
0.6% |
9.2% |
SHUKRA PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about SHUKRA PHARMACEUTICALS Financials
How the annual revenues of SHUKRA PHARMACEUTICALS have changed ?
The Revenues of SHUKRA PHARMACEUTICALS have increased by 187.19% YoY .
How the Earnings per Share (EPS) of SHUKRA PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of SHUKRA PHARMACEUTICALS has increased by 50.44 % YoY .
Check out Intrinsic Value of Peers of SHUKRA PHARMACEUTICALS
Compare Stock Analytics of Peers of SHUKRA PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
